Clinical Trial Details


Back to Clinical Trials Database

Intermittent androgen deprivation in patients with stage D2 prostate cancer-Phase III

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 21-Apr-1999
Date Step1 close: 01-Sep-2008
Date Step2 close: 01-Jun-2009
Data management at EORTC No
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 1512
Treatment Bicalutamide, Goserelin
Study Staff
Type of cancer
Participating groups EORTC Genito-Urinary Cancers Group
NCIC Clinical Trial Group
Southwest Oncology Group-US
Cancer and Leukemia Group B
Eastern Cooperative Oncology Group
National Cancer Institute
Protocol summary
NCT number NCT00002651